Sign In

Courtney Coburn Glavin

Researcher | Clinician

Courtney Coburn Glavin is a highly educated professional with a diverse background in communication sciences and disorders, audiology, and biomedical engineering.

She holds a Doctor of Philosophy (PhD) in Communication Sciences and Disorders from Northwestern University, where she also completed a Doctor of Audiology (Au.D.) and a Bachelor of Science (B.S.) degree in the same field.

Additionally, Courtney pursued graduate coursework in Speech-Language-Hearing Sciences and Biomedical Engineering at the University of Minnesota, showcasing her commitment to expanding her knowledge across related disciplines.

Throughout her career, Courtney has held various positions that have contributed to her expertise. She served as an Assistant Professor at the University of Washington, demonstrating her dedication to academia and education.

Her industry experience includes roles as a Feature Manager and Research Audiologist at Starkey Hearing Technologies, where she likely honed her skills in product development and research.

Courtney has also been involved in leadership roles, having been a Board of Directors - Programs Subcommittee Chair at the Student Academy of Audiology (SAA). This highlights her organizational and managerial abilities within professional associations.

Furthermore, she gained hands-on experience as an Audiology Extern at UPMC, further solidifying her practical skills in the field of audiology.

Highlights

Sep 3 · linkedin

I’m happy to share that I’m starting a new position as Assistant Professor at University of Washington!

Jan 12 · linkedin

This piece in the Atlantic caught my eye. Disruptive #science (i.e., groundbreaking #research) is in decline. "We should be living in a golden age of creativity in science and technology...but America is running out of new ideas."

Curious to hear the thoughts of fellow scientists and clinicians - is this true in #auditoryscience & #audiology? On one hand, the tools we have to treat #hearingloss are stronger than ever before. On the other hand, our gold standard diagnostic test has remained essentially unchanged for over 60 years.

Can and should we change course here? How? What is needed from scientists/researchers, clinicians, funding agencies, etc.?

(and what do you all think about another omnipresent problem not directly covered by this article: timely and smooth translation of groundbreaking scientific discoveries into clinical practice!)

Courtney Coburn Glavin
Add to my network

Location

Seattle, Washington, United States